Scott Lowe
Impact in
- Aging top 1%
- Cancer Research top 0.5%
- MicroRNA in disease regulation
Papers in ⓘ
-
- Gastrointestinal Tumor Research and Treatment 4
- Oncology 18
- Cancer-related Molecular Pathways 6
- Co-authors
- Mila E. McCurrach (2 shared papers)Athena W. Lin (1 shared paper)Manuel Serrano (1 shared paper)Carol Prives (2 shared papers)Pascal Pineau (1 shared paper)Agnès Marchio (1 shared paper)Vincenzo Mazzaferro (1 shared paper)Anne Dejean (1 shared paper)
- Journals
- Environmental Science and Pollution Research (6 papers)European Journal of Clinical Pharmacology (3 papers)Frontiers in Pharmacology (3 papers)Frontiers in Immunology (2 papers)Cell Reports (2 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Scott Lowe
67 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Aging 265
- Cancer Research 1.7k
- Oncology 2.6k
- Physiology 1.8k
- Molecular Biology 4.5k
Countries citing papers authored by Scott Lowe
This map shows the geographic impact of Scott Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Lowe more than expected).
Fields of papers citing papers by Scott Lowe
This network shows the impact of papers produced by Scott Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Lowe. The network helps show where Scott Lowe may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Lowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a Hit paper breakdown → | 1997 | 4043 |
| 2 | Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway Hit paper breakdown → | 2012 | 696 |
| 3 | miR-221 overexpression contributes to liver tumorigenesis Hit paper breakdown → | 2009 | 606 |
| 4 | E1A signaling to p53 involves the p19ARFtumor suppressor Hit paper breakdown → | 1998 | 518 |
| 5 | 1995 | 165 | |
| 6 | 2022 | 96 | |
| 7 | 2006 | 75 | |
| 8 | 2022 | 68 | |
| 9 | 2022 | 55 | |
| 10 | 2022 | 37 | |
| 11 | 2022 | 34 | |
| 12 | 2022 | 33 | |
| 13 | 2023 | 32 | |
| 14 | 2022 | 30 | |
| 15 | 2023 | 29 | |
| 16 | 2022 | 23 | |
| 17 | 1997 | 21 | |
| 18 | 2021 | 21 | |
| 19 | 2022 | 21 | |
| 20 | 2022 | 20 |
About Scott Lowe
Scott Lowe is a scholar working on Gastroenterology, Oncology, Health, Toxicology and Mutagenesis, Cancer Research and Pollution, having authored 69 papers that have together received 7.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Cancer, Lipids, and Metabolism (5 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Air Quality and Health Impacts (4 papers), Gastric Cancer Management and Outcomes (4 papers), Pesticide Exposure and Toxicity (4 papers), Sarcoma Diagnosis and Treatment (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Aging (265 citations), Cancer Research (1.7k citations), Oncology (2.6k citations), Physiology (1.8k citations) and Molecular Biology (4.5k citations). Scott Lowe has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Mila E. McCurrach, Athena W. Lin, Manuel Serrano, Carol Prives, Pascal Pineau, Agnès Marchio, Vincenzo Mazzaferro, Anne Dejean, Stefano Volinia and Benoı̂t Terris. Their work appears in journals such as Environmental Science and Pollution Research, European Journal of Clinical Pharmacology, Frontiers in Pharmacology, Frontiers in Immunology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.